Bttt
CEO and Founder
Cate Dyer
Pic here
https://www.linkedin.com/pub/cate-dyer/27/592/857
Cate Dyer, CEO, StemExpress LLC
Dyer founded her biotechnology company in Placerville with only $9,000. Four years later StemExpress, which provides human blood, bone marrow, human primary cells and tissue for medical research, ranks No. 363 on the Inc. 500 list of fastest-growing private companies, with 1,315 percent growth over a three-year period.
Interesting Facts:
Best advice you ever got: “Identify what your greatest weaknesses are and hire those strengths immediately.”
Goal by age 40: “Truly brilliant ideas take place when we slow down, take in our environment, and see what’s missing. So on that note, I want to start spending at least one month living in another country, every year.”
Biggest whoops: “Letting fear hold me back.”
Favorite possession: Everything Apple
Guilty pleasure: Motocross/Motorcycle Riding
I am passionate about: “Revolutionizing medical research, directly improving patient care, being an instrument of change and absolutely enjoying life to its fullest.”
CEO & Founder
StemExpress
May 2010 – Present (5 years 3 months)Placerville, California
Cate Dyer is the Founder and CEO of StemExpress with over 13 years experience in patient care and medical research. She began working at Santa Barbara Cottage Hospital at age 19 in the departments of Emergency Medicine, Surgery and Psychology, she concurrently worked extensively with human dissections and organ donations. During that time, Cate earned a A.A.S in Liberal Arts from Santa Barbara City College, and later an additional B.A. in Sociology from California State University, Sacramento. At age 23, Cate concurrently worked for a prominent Bay Area human tissue provider as a procurement specialist, as well as opened her first company, which managed corporate building contracts throughout California. It wasn’t until 2010 that she struck a balance between her natural business acumen and love of medicine by founding StemExpress, which has since become the new high standard in human tissue, blood and cell procurement and isolation for top research universities, pharmaceutical companies and hospitals globally.